| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2022 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | OT2CA278681 | PROMINENT - IARC | 000 | 1 | NIH | 10/13/2026 | $0 |
|
 | Issue Date FY: 2026 ( Subtotal = $1,971,832 ) |
| | 2026 | 2026 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R01CA307572 | Early Biomarkers for HPV-Driven Cancers: Modeling Risks and Screening | 001 | 1 | NIH | 9/14/2026 | $0 |
| | 2026 | 2026 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R01CA307572 | Early Biomarkers for HPV-Driven Cancers: Modeling Risks and Screening | 000 | 1 | NIH | 9/7/2026 | $322,139 |
| | 2026 | 2026 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 002 | 4 | NIH | 8/24/2026 | $147,753 |
| | 2026 | 2026 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 003 | 4 | NIH | 9/2/2026 | $95,633 |
| | 2026 | 2026 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 004 | 4 | NIH | 9/3/2026 | $301,188 |
| | 2026 | 2026 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | U01CA289226 | The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk | 000 | 3 | NIH | 5/1/2026 | $522,732 |
| | 2026 | 2026 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | U01CA289226 | The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk | 001 | 3 | NIH | 6/11/2026 | $35,845 |
| | 2026 | 2026 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R01CA316401 | Proteogenomic framework for precision lung cancer screening | 000 | 1 | NIH | 8/11/2026 | $546,542 |
| | 2026 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 001 | 3 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 000 | 3 | NIH | 11/24/2025 | $0 |
| | 2026 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | U01CA257679 | InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies. | 000 | 5 | NIH | 7/13/2026 | $0 |
| | 2026 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R01CA033193 | IARC Monographs on the Identification of Carcinogenic Hazards to Humans | 000 | 43 | NIH | 6/4/2026 | $0 |
| | 2026 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R01CA033193 | IARC Monographs on the Identification of Carcinogenic Hazards to Humans | 000 | 43 | NIH | 6/4/2026 | $0 |
| | 2026 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 ave Tony Garnier | LYON | LYON | | | FRA | NU58DP007177 | The IARC Handbooks of Cancer Prevention - Evidence-based evaluations of primary and secondary cancer prevention approaches | 02 | 3 | CDC | 11/10/2025 | $0 |
| | 2026 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R01CA262164 | The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening | 000 | 3 | NIH | 2/13/2026 | $0 |
|
 | Issue Date FY: 2025 ( Subtotal = $3,486,153 ) |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R01CA262164 | The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening | 000 | 4 | NIH | 9/1/2025 | $660,204 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R01CA033193 | IARC Monographs on the Identification of Carcinogenic Hazards to Humans | 000 | 43 | NIH | 9/8/2025 | $880,253 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R01CA033193 | IARC Monographs on the Identification of Carcinogenic Hazards to Humans | 000 | 43 | NIH | 9/8/2025 | $110,000 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 002 | 3 | NIH | 9/19/2025 | $91,214 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 003 | 3 | NIH | 9/22/2025 | $301,187 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 001 | 3 | NIH | 9/17/2025 | $327,376 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | U01CA257679 | InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies. | 000 | 5 | NIH | 8/26/2025 | $544,532 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | U01CA289226 | The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk | 000 | 2 | NIH | 4/15/2025 | $514,250 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | U01CA289226 | The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk | 002 | 2 | NIH | 9/25/2025 | $35,845 |
| | 2025 | 2025 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | U01CA289226 | The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk | 001 | 2 | NIH | 9/24/2025 | $21,292 |
| | 2025 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 000 | 2 | NIH | 9/15/2025 | $0 |
| | 2025 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R01CA262164 | The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening | 001 | 3 | NIH | 9/2/2025 | $0 |
| | 2025 | 2023 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R01CA244559 | African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus) | 000 | 4 | NIH | 6/27/2025 | $0 |
| | 2025 | 2022 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | OT2CA278681 | PROMINENT - IARC | 000 | 1 | NIH | 5/7/2025 | $0 |
| | 2025 | 2022 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R03DE030257 | Germline risk of oral and oropharyngeal cancers across diverse populations | 000 | 2 | NIH | 2/6/2025 | $0 |
| | 2025 | 2022 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON 7TH | | | | FRA | R21CA256902 | The role of Epstein Barr Virus and Human Papilloma Virus Co-infection in Conjunctival Squamous Cell Carcinoma. | 000 | 2 | NIH | 10/29/2024 | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $3,678,099 ) (Continued on the next page) |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 ave Tony Garnier | LYON | LYON | | | FRA | NU58DP007177 | The IARC Handbooks of Cancer Prevention - Evidence-based evaluations of primary and secondary cancer prevention approaches | 01 | 3 | CDC | 8/14/2024 | $0 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 ave Tony Garnier | LYON | LYON | | | FRA | NU58DP007177 | The IARC Handbooks of Cancer Prevention - Evidence-based evaluations of primary and secondary cancer prevention approaches | 00 | 3 | CDC | 7/2/2024 | $200,000 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | U01CA289226 | The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk | 000 | 1 | NIH | 3/21/2024 | $586,334 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | U01CA257679 | InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies. | 000 | 4 | NIH | 7/31/2024 | $510,942 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R37CA275824 | A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | 000 | 2 | NIH | 9/3/2024 | $491,802 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R01CA033193 | IARC Monographs on the Identification of Carcinogenic Hazards to Humans | 000 | 42 | NIH | 7/22/2024 | $836,241 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R01CA033193 | IARC Monographs on the Identification of Carcinogenic Hazards to Humans | 000 | 42 | NIH | 7/22/2024 | $104,500 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | OT2CA278681 | PROMINENT - IARC | 001 | 1 | NIH | 9/5/2024 | $469,419 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | OT2CA278681 | PROMINENT - IARC | 002 | 1 | NIH | 9/13/2024 | $33,503 |
| | 2024 | 2024 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R01CA262164 | The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening | 000 | 3 | NIH | 8/8/2024 | $452,301 |
| | 2024 | 2023 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | UH3CA202721 | Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries | 000 | 5 | NIH | 7/12/2024 | -$6,943 |
| | 2024 | 2022 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | OT2CA278681 | PROMINENT - IARC | 000 | 1 | NIH | 6/6/2024 | $0 |
| | 2024 | 2021 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | UH3CA202730 | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | 000 | 5 | NIH | 2/1/2024 | $0 |
| | 2024 | 2021 | CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | 25 AVE TONY GARNIER | LYON | | | | FRA | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 000 | 5 | NIH | 10/24/2023 | $0 |
|